Paper Details

  1. Home
  2. Paper Details

Evaluation of a nutritional supplement for the alleviation of pain associated with feline degenerative joint disease: a prospective, randomized, stratified, double-blind, placebo-controlled clinical trial.

Author: CunninghamRachael, GruenMargaret E, LascellesB Duncan X, ThomsonAndrea

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled Trial, VeterinaryRandomized controlled trials involving animals. They evaluate the efficacy and safety of treatment methods.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

This study evaluated the pain-alleviating and activity-enhancing effects of glucosamine/chondroitin sulfate (Dasuquin) in cats with degenerative joint disease (DJD). The nutritional supplement was hypothesized to produce pain-relieving and activity-enhancing effects in cats with painful DJD.
Paper Details　
Original Abstract of the Article :
The purpose of this study was to evaluate the pain-alleviating and activity-enhancing effects of glucosamine/chondroitin sulfate (Dasuquin) in cats that had degenerative joint disease (DJD) and owner-noted mobility/activity impairment. We hypothesized that the nutritional supplement would produce pa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1098612X211053484

データ提供：米国国立医学図書館（NLM）

Easing the Pain: A Study on Glucosamine/Chondroitin for Cats with Degenerative Joint Disease

The world of veterinary medicine is constantly evolving, with new insights and treatments emerging all the time. This study delves into the realm of feline health, specifically focusing on the pain-alleviating potential of glucosamine/chondroitin sulfate, a common dietary supplement. The study used a randomized, controlled design to evaluate the effects of this supplement on cats suffering from degenerative joint disease (DJD). This condition, similar to osteoarthritis in humans, can severely impact a cat's mobility and overall quality of life.

A Glimpse of Hope for Feline Mobility

The study's findings show that glucosamine/chondroitin sulfate (Dasuquin) may be beneficial for cats with DJD. The results revealed a positive impact on pain relief and improved activity levels in these cats. This is a significant development, as it offers a potential treatment option for a condition that can be quite debilitating for our feline companions.

A Step Towards a Better Life for Cats

If your cat is experiencing joint pain and reduced mobility, it's essential to consult with your veterinarian. They can provide a proper diagnosis and discuss treatment options, which may include this promising nutritional supplement. Remember, early intervention can significantly improve the quality of life for cats with DJD, allowing them to enjoy a more active and fulfilling existence.

Dr.Camel's Conclusion

As a fellow researcher, I'm always fascinated by the advancements in veterinary medicine. This study provides a ray of hope for cats suffering from DJD, suggesting that glucosamine/chondroitin may alleviate their pain and improve their mobility. It's a reminder of the power of science in improving the lives of our furry friends, even in the vast and sometimes harsh desert of medical unknowns.

Date :
  1. Date Completed 2022-09-28
  2. Date Revised 2022-11-04
Further Info :

Pubmed ID

34719996

DOI: Digital Object Identifier

10.1177/1098612X211053484

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.